» Articles » PMID: 35833127

Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus-Like Inflammation

Abstract

Cutaneous lupus erythematosus (CLE) is an autoimmune skin disease characterized by a strong IFN signature, normally associated with type I IFNs. However, increasing evidence points to an additional role for IFNγ, or at least a pathogenic T effector subset dependent on IFNγ, for disease progression. Nevertheless, Th2 effector subsets have also been implicated in CLE. We have now assessed the role of specific T cell subsets in the initiation and persistence of skin disease using a T cell-inducible murine model of CLE, dependent on KJ1-26 T cell recognition of an ovalbumin fusion protein. We found that only Th2-skewed cells, and not Th1-skewed cells, induced the development of skin lesions. However, we provide strong evidence that the Th2 disease-initiating cells convert to a more Th1-like functional phenotype by the time the skin lesions are apparent. This phenotype is maintained and potentiates over time, as T cells isolated from the skin, following a second induction of self-antigen, expressed more IFN-γ than T cells isolated at the time of the initial response. Transcriptional analysis identified additional changes in the KJ1-26 T cells at four weeks post injection, with higher expression levels of interferon stimulated genes (ISGs) including , and . Further, injection of IFN-γ-/- T cells faied to induce skin disease in mice. We concluded that Th2 cells trigger skin lesion formation in CLE, and these cells switch to a Th1-like phenotype in the context of a TLR7-driven immune environment that is stable within the T cell memory compartment.

Citing Articles

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes.

Rabin A, Bello E, Kumar S, Zeki D, Afshari K, Deshpande M Sci Rep. 2024; 14(1):21793.

PMID: 39294186 PMC: 11411093. DOI: 10.1038/s41598-024-67769-1.


Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery.

Ikuno Y, Yamaguchi A, Takahashi T, Fujimoto N Acta Derm Venereol. 2024; 104:adv21502.

PMID: 38738771 PMC: 11107829. DOI: 10.2340/actadv.v104.21502.


Functional heterogeneity of human skin-resident memory T cells in health and disease.

Strobl J, Haniffa M Immunol Rev. 2023; 316(1):104-119.

PMID: 37144705 PMC: 10952320. DOI: 10.1111/imr.13213.


Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.

Niebel D, de Vos L, Fetter T, Bragelmann C, Wenzel J Am J Clin Dermatol. 2023; 24(4):521-540.

PMID: 37140884 PMC: 10157137. DOI: 10.1007/s40257-023-00774-8.


Sex bias in lymphocytes: Implications for autoimmune diseases.

Dodd K, Menon M Front Immunol. 2022; 13:945762.

PMID: 36505451 PMC: 9730535. DOI: 10.3389/fimmu.2022.945762.


References
1.
Di Pilato M, Kfuri-Rubens R, Pruessmann J, Ozga A, Messemaker M, Cadilha B . CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell. 2021; 184(17):4512-4530.e22. PMC: 8719451. DOI: 10.1016/j.cell.2021.07.015. View

2.
Hegazy A, Peine M, Helmstetter C, Panse I, Frohlich A, Bergthaler A . Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity. 2010; 32(1):116-28. DOI: 10.1016/j.immuni.2009.12.004. View

3.
Ghoreishi M, Dutz J . Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev. 2009; 8(6):484-7. DOI: 10.1016/j.autrev.2009.02.028. View

4.
Randolph D, Stephens R, Carruthers C, Chaplin D . Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest. 1999; 104(8):1021-9. PMC: 408580. DOI: 10.1172/JCI7631. View

5.
Gomez D, Correa P, Gomez L, Cadena J, Molina J, Anaya J . Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?. Semin Arthritis Rheum. 2004; 33(6):404-13. DOI: 10.1016/j.semarthrit.2003.11.002. View